The inhibition by beta-adrenoceptor blocking agents of calcium uptake into and efflux from isolated sarcoplasmic vesicles.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001572:Benzofurans / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003597:Cytosine Nucleotides / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D006150:Guanine Nucleotides / Q000494:pharmacology; D006868:Hydrolysis; D066298:In Vitro Techniques; D007292:Inosine Nucleotides / Q000494:pharmacology; D007700:Kinetics; D009132:Muscles / Q000166:cytology / Q000201:enzymology; D010096:Oxprenolol / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D011817:Rabbits; D012519:Sarcoplasmic Reticulum / Q000378:metabolism*; D013015:Sotalol / Q000494:pharmacology; D014500:Uracil Nucleotides / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D001572:Benzofurans; D003597:Cytosine Nucleotides; D004983:Ethanolamines; D006150:Guanine Nucleotides; D007292:Inosine Nucleotides; D011437:Propylamines; D014500:Uracil Nucleotides; D010096:Oxprenolol; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D011433:Propranolol; D013015:Sotalol; D000251:Adenosine Triphosphatases; D011217:Practolol; D002118:Calcium